JP2020530472A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020530472A5 JP2020530472A5 JP2020507622A JP2020507622A JP2020530472A5 JP 2020530472 A5 JP2020530472 A5 JP 2020530472A5 JP 2020507622 A JP2020507622 A JP 2020507622A JP 2020507622 A JP2020507622 A JP 2020507622A JP 2020530472 A5 JP2020530472 A5 JP 2020530472A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- formulated
- treatment
- fever
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 206010037660 Pyrexia Diseases 0.000 claims 2
- 201000010848 Schnitzler Syndrome Diseases 0.000 claims 2
- 206010048998 Acute phase reaction Diseases 0.000 claims 1
- 208000006820 Arthralgia Diseases 0.000 claims 1
- 206010006002 Bone pain Diseases 0.000 claims 1
- 206010019842 Hepatomegaly Diseases 0.000 claims 1
- 208000008771 Lymphadenopathy Diseases 0.000 claims 1
- 206010041660 Splenomegaly Diseases 0.000 claims 1
- 206010052568 Urticaria chronic Diseases 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 208000024376 chronic urticaria Diseases 0.000 claims 1
- 208000018555 lymphatic system disease Diseases 0.000 claims 1
- 238000011206 morphological examination Methods 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 238000007910 systemic administration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762544617P | 2017-08-11 | 2017-08-11 | |
| US62/544,617 | 2017-08-11 | ||
| PCT/US2018/045752 WO2019032672A1 (en) | 2017-08-11 | 2018-08-08 | METHOD OF TREATING SCHNITZLER SYNDROME |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020530472A JP2020530472A (ja) | 2020-10-22 |
| JP2020530472A5 true JP2020530472A5 (https=) | 2021-09-24 |
Family
ID=65271433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020507622A Pending JP2020530472A (ja) | 2017-08-11 | 2018-08-08 | シュニッツラー症候群の治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20200170990A1 (https=) |
| EP (1) | EP3664786B1 (https=) |
| JP (1) | JP2020530472A (https=) |
| AU (1) | AU2018313164A1 (https=) |
| WO (1) | WO2019032672A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021076444A1 (en) | 2019-10-14 | 2021-04-22 | Olatec Therapeutics Llc | Methods for treating breast cancer |
| EP4126015A4 (en) * | 2020-03-31 | 2024-04-24 | Olatec Therapeutics, Inc. | METHODS FOR PREVENTING OR TREATMENT OF LUNG INFECTIONS AND PNEUMONIA |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013006708A (es) * | 2010-12-15 | 2013-09-13 | Olatec Ind Llc | Composicion de 3-metanosulfonilpropionitrilo para el tratamiento de la inflamacion y el dolor. |
| CA2913154A1 (en) * | 2013-05-21 | 2014-11-27 | Virginia Commonwealth University | Cryopyrin inhibitors for preventing and treating inflammation |
| BR112018003212A2 (en) * | 2015-08-17 | 2018-09-25 | Twi Biotechnology, Inc. | diacerein or analogues thereof to inhibit asc expression, nlrp3 expression and / or inflammasome nlrp3 complex formation |
| WO2017079352A2 (en) * | 2015-11-04 | 2017-05-11 | Idera Pharmaceuticals, Inc. | Compositions for inhibiting nlrp3 gene expression and uses thereof |
| EP3565540B1 (en) * | 2017-01-06 | 2023-12-06 | Olatec Therapeutics LLC | A pharmaceutical composition for use in treating cardiovascular diseases |
-
2018
- 2018-08-08 JP JP2020507622A patent/JP2020530472A/ja active Pending
- 2018-08-08 WO PCT/US2018/045752 patent/WO2019032672A1/en not_active Ceased
- 2018-08-08 EP EP18844011.9A patent/EP3664786B1/en active Active
- 2018-08-08 AU AU2018313164A patent/AU2018313164A1/en not_active Abandoned
-
2020
- 2020-02-10 US US16/785,917 patent/US20200170990A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016518387A5 (https=) | ||
| CY1124432T1 (el) | Φαρμακευτικες συνθεσεις που αποτελουν ν-(3,5-διμεθοδυφαινυλ)-ν'-(1-μεθυλαιθυλ)-ν-[3-(1--μεθυλ-1η-πυραζολ-4-υλ)κινοοξαλιν-6-υλ]αιθανο-1,2-διαμινη | |
| JP2016034978A5 (https=) | ||
| JP2018193377A5 (https=) | ||
| EA202191079A1 (ru) | Способы лечения синдрома ретта с применением фенфлурамина | |
| JP2018021046A5 (https=) | ||
| JP2018048154A5 (https=) | ||
| JP2017524735A5 (https=) | ||
| JP2017501848A5 (https=) | ||
| JP2020193206A5 (https=) | ||
| JP2016523260A5 (https=) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2016532667A5 (https=) | ||
| JP2017222722A5 (https=) | ||
| JP2020530472A5 (https=) | ||
| JP2019535760A5 (ja) | ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法 | |
| RU2016148887A (ru) | Пиридиновые соединения пладиенолида и способы применения | |
| JP2009501801A5 (https=) | ||
| JP2016512817A5 (https=) | ||
| JP2017531673A5 (https=) | ||
| JP2017533220A5 (https=) | ||
| JP2016510343A5 (https=) | ||
| AR113906A1 (es) | Régimen con cladribina para tratar formas progresivas de la esclerosis múltiple | |
| ZA202204907B (en) | Orally disintegrating pharmaceutical compositions of apixaban | |
| EA201600486A1 (ru) | Фармацевтические композиции, включающие антикоагулянт n-(5-хлорпиридин-2-ил)-2-({4-[этанимидоил(метил)амино]бензоил}амино)-5-метилбензамид |